News

2017 has been an exciting year for the clinical trials industry on many fronts, driven by new methods, regulation, and technology, but what is to come in 2018?

Mobile health devices are poised to transform medical care-and with it the medical device market.

Outsourcing safety responsibilities to functional service providers (FSPs) during clinical trials and post-approval can help small-to-medium-sized enterprises balance their workload and maintain best-practice operations.

Today, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.

This article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.

Outlining the techniques for anonymization of clinical study reports and the identification and redaction of commercially confidential information to comply with EMA's Policy 0070 on trial data disclosure and transparency.

Metabolomics can make a positive impact from early drug discovery through clinical development and beyond.

Updated employee announcements, business news, awards, and recognition in the industry today.

The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.

Investigators aim to increase the efficiency and consistency of FDA’s Bioresearch Monitoring program.